Clinical Trials List
Protocol NumberES-CCAR01-A3301
Active
2024-05-01 - 2027-06-30
Phase I/II
Recruiting1
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
EVER SUPREME BIO TECHNOLOGY CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Yao-Chung Wu Division of General Surgery
- Su-Peng Yeh Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
- Chih-Yen Tu Division of Thoracic Medicine
- Wei-Ching Lin Division of Others -
- 張伸吉 Division of Colorectal Surgery
- Te-Chun Hsia Division of Thoracic Medicine
- 林宏霖 Division of Orthopedics
- Liang-Chih Liu Division of General Surgery
- Chun-Chung Chen Division of Orthopedics
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
49 participants
-
Global
49 participants
